Features | Partner Sites | Information | LinkXpress
Sign In
Bio-Rad Diabetes Division
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES

Gene Variants Indicate Increased Susceptibility to Colon Cancer

By Labmedica International staff writers
Posted on 08 Mar 2012
The imbalance observed in the human tumor tissues appears to be the result of a complex, multistep process by the enzyme sarcoma tyrosine kinase (SRC).

Some tissues, like liver, have just one type of variant of the nuclear receptor hepatocyte nuclear factor 4α (HNF4α), but the colon has both P1 and P2 variants. The P1 variant is found in the nuclei of cells in the normal colon, but in the human colon cancer samples this variant is frequently either absent or located outside of the nucleus and, presumably, no longer functional.

An international team led by cell biologists at the University of California, (Riverside, CA, USA) has uncovered a new insight into colon cancer. The team analyzed about 450 human colon cancer specimens and found that in nearly 80% of them, the variants of the HNF4A gene are out of balance. The team used both SRC kinase assays and human colonic adenocarcinoma tissue staining. Tissue microarrays (TMAs) were constructed with 1.0 mm cores from morphologically representative areas of the original archived paraffin blocks, the central region of the tumor, deep advancing tumor front, and adjacent non-neoplastic mucosa using an Advanced Tissue Arrayer, ATA-100.

SRC kinase has been known to be activated in colon cancer but, until now, it was not known to act on the HNF4α protein. The cell biologists found that activated SRC modifies the P1 but not the P2 variant. The net result is loss of the P1 variant in the nuclei of cells in the colon. Another factor that increased a person's susceptibility to the disease was specific single nucleotide polymorphisms or SNPs located in the HNF4A gene. An SNP is a DNA sequence variation, a minor change in the genomic sequence that accounts for the variations seen between individuals. SNPs are the most common type of genetic variation among people. The SRC kinase assays and the ATA-100 used are manufactured by Millipore (Billerica, MA, USA).

The authors concluded that that increased staining for active SRC is associated with a loss of nuclear P1-HNF4α in a sizeable cohort of human colorectal tumors. Their findings suggest a unique link between an oncogenic kinase, a potent differentiation factor, and human colon cancer. Frances M. Sladek, PhD, a professor of cell biology and toxicologist, who was the lead author of the study said, "Loss of nuclear P1 HNF4α protein in the colon may be an early sign of colon cancer. A healthy colon has a good but delicate balance of the two HNF4A variants. If you could prevent the loss of the P1 variant via drugs, you might be able to maintain a normal colon and prevent colon cancer." The study was published on Febraury 14, 2012, in the Proceedings of the National Academy of Science of the United States (PNAS).

Related Links:
University of California, Riverside
Millipore


DiagCor Bioscience
PURITAN MEDICAL
77 ELEKTRONIKA
comments powered by Disqus
Sekisui Diagnostics

Channels

Clinical Chemistry

view channel
Image:  The Agilent 6890 GC with 5973 Mass Spectrometer and Tekmar Velocity XPT Purge & Trap (Photo courtesy of Gen Tech).

Low Levels of Prohormone Predicts Coronary Heart Disease

The adrenal sex hormone dehydroepiandrosterone (DHEA), which is present in serum mainly as the sulfate DHEA-S, is the most abundant steroid hormone in human blood and its levels decline dramatically with age.... Read more

Microbiology

view channel
Image: The causative parasite of Chagas disease Trypanosoma cruzi in a blood film (Photo courtesy of the CDC - US Centers for Disease Control and Prevention).

Undiagnosed Chagas Disease Emerging as Public Health Threat

Chagas disease or American trypanosomiasis is typically spread to people through the feces of blood-sucking triatomine bugs sometimes called kissing bugs because they feed on people's faces during the night.... Read more

Pathology

view channel
Image: The Isolation by Size of Epithelial Tumor cells (ISET) technology (Photo courtesy of Rarecells Diagnostics).

Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer

Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer and migration of circulating tumor cells (CTCs) into the blood stream is an early event that occurs during carcinogenesis.... Read more

Industry News

view channel

Oncology Companion Diagnostics Sector Grows to Over USD 1 Billion

The market for diagnostic test and pharmaceutical drug pairs for cancer treatment has grown significantly, according to the report “Companion Diagnostic Markets” from healthcare market research firm Kalorama Information (New York City, NY, USA). The global companion diagnostics (CDx) market is valued at about USD 1.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.